1,314
Views
8
CrossRef citations to date
0
Altmetric
Editorial

Pulse pressure as a predictor of stroke

, &
Pages 165-167 | Published online: 09 Jan 2014

References

  • Williams B, Poulter NR, Brown MJ et al. British Hypertension Society guidelines for hypertension managment 2004 (BHS-IV): summary. Br. Med. J.328, 634–640 (2004).
  • World Health Organization ISoHWG. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J. Hypertens.21, 1983–1992 (2003).
  • Nichols WW, O’Rourke MF. McDonald’s Blood Flow in Arteries. 4th Edition. A Hodder Arnold Publication, London, UK (1998).
  • O’Rourke M, Frohlich ED. Pulse pressure: is this a clinically useful risk factor? Hypertension34(3), 372–374 (1999).
  • Franklin SS, Gustin W, Wong ND et al. Hemodynamic patterns of age-related changes in blood pressure The Framingham Heart Study. Circulation96, 308–315 (1997).
  • Franklin SS, Larson MG, Khan SA et al. Does the relation of blood pressure to coronary heart disease risk change with aging? Circulation103, 1245–1249 (2001).
  • Blacher J, Staessen JA, Girerd X et al. Pulse pressure not mean pressure determines cardiovascular risk in older hypertensive patients. Arch. Intern. Med.160, 1085–1089 (2000).
  • Gasowski J, Fagard RH, Staessen JA et al. Pulsatile blood pressure component as predictor of mortality in hypertension: a meta-analysis of clinical trial control groups. J. Hypertens.20(1), 145–151 (2002).
  • Franklin SS, Larson MG, Khan SA et al. Does the relation of blood pressure to coronary heart disease risk change with aging? Circulation103, 1245–1249 (2001).
  • Liao D, Arnett DK, Tyroler HA et al. Arterial stiffness and the development of hypertension. Hypertension34, 201–206 (1999).
  • Chae CU, Pfeffer MA, Glynn RJ, Mitchell GF, Taylor JO, Hennekens CH. Increased pulse pressure and risk of heart failure in the elderly. JAMA281, 634–643 (1999).
  • Staessen JA, Fagard R, Thijs L, Celis H. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet350, 757–764 (1997).
  • Liu L, Wang J-G, Gong L, Liu G, Staessen JA for the Systolic Hypertension in China (Syst-China) Collaborative Group. Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. J. Hypertens.16, 1823–1829 (1998).
  • Amery A, Birkenhager W, Brixko P, Bulpitt C, Clement D, Deruyttere M. Mortality and morbidity results from the European Working Party on High blood pressure in the Elderly trial. Lancet1(8442), 1349–1354 (1985).
  • Staessen JA, Thijsa L, O’Brienb ET et al. Ambulatory pulse pressure aspredictor of outcome in older patients with systolic hypertension. Am. J. Hypertens15, 835–843 (2002).
  • Vemmos KN, Tsivgoulis G, Spengos K et al. Pulse pressure in acute stroke is an independent predictor of long-term mortality. Cerebrovasc. Dis.18(1), 30–36 (2004).
  • Voyaki SM, Efstratopoulos AD, Baltas A. Pulse pressure as a predictor factor for survival in patients with a acute ischaemic stroke. Am. J. Hypertens.17(5), 234–235 (2004).
  • Tsivgoulis G, Spengos K, Zakopoulos N et al. Twenty four hour pulse pressure predicts long term recurrence in acute stroke patients. J. Neurol. Neurosurg. Psychiatr.76, 1360–1365 (2005).
  • Sprigg N, Gray LJ, Bath PMW et al. Relationship between outcome and baseline blood pressure and other haemodynamic mreasures in acute ischaemic stroke: data from the TAIST trial. J. Hypertens.24(7), 1413–1417 (2006).
  • Cushman WC, Materson BJ, Williams DW, Reda DJ, Agents ftVACSGoA. Pulse pressure changes with six classes of antihypertensive agents in a randomized, controlled trial. Hypertension38, 953–957 (2001).
  • Neaton JD, Grimm RH Jr, Prineas RJ et al. Treatment of mild hypertension study. Final results. JAMA270(6), 713–724 (1993).
  • ALLHAT Collaborative Research Group. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA283(15), 1967–1975 (2000).
  • ALLHAT Officers and Coordinators for the ALLHAtT Collaborative Research Group. Major outcomes in high risk hypertensive patients randomised to angiotensin-converting enzyme inhibitor or calcium channel blockers vs antihypertensive and lipid-lowering treatment to prevent heart attack. JAMA288, 2981–2997 (2002).
  • Gray LJ, Sprigg N, Rashid PA, Willmot M, Bath PMW. Effect of nitric oxide donors on blood pressure and pulse pressure in acute and subactue stroke. J. Stroke Cerebrovasc. Dis.15(6), 245–249 (2006).
  • de la Sierra A, Muñoz A, Arcos E, López JS, Relats J. The effect of treatment with eprosartan on pulse pressure: factors predicting response. Can. J. Cardiol.20(Suppl. C), C:17C–22C (2004).
  • Robles NR, Martín-Agueda B, López-Muñoz F, Alamo C. Effectiveness and safety of eprosartan on pulse pressure for the treatment of hypertensive patients. Int. J. Clin. Pract.59(4), 478–484 (2005).
  • de la Sierra A. Effects of eprosartan on pulse pressure. J. Clin. Basic Cardiol.8, 11–14 (2005).
  • The ENOS Trial Investigators. Glyceryl trinitrave vs. control, and continuing vs. stopping temporarily prior antihypertensive therapy, in acute stroke: rationale and design of the Efficacy of Nitric Oxide in Stroke (ENOS) trial (ISRCTN99414122). Int. J. Stroke1, 245–249 (2006).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.